AstraZeneca shares slump after Phase 3 lung cancer drug study
July 03, 2023 at 08:35 AM EDT
AstraZeneca shares fell Monday after a late-stage study on a lung cancer drug disappointed investors.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|